glow vs klow

updated October 25, 2026

glow (tier A) vs klow (tier A): what each is, why each got its grade, half-life and source counts side by side.

glow · tier A

klow without kpv. ghk-cu, bpc-157 and tb-500, with ghk-cu dominant by weight.

tier rationale

a three-peptide blend of GHK-Cu + BPC-157 + TB-500, heavily weighted toward GHK-Cu (typical ratio 50:10:10). emerged from peptide clinics in parallel with KLOW but with a cosmetic-first positioning rather than a gut-inflammation angle. none of the three components is FDA-approved. the blend has no formal clinical research. A-tier for the same reason KLOW is: strong component-level evidence, consistent user reports, but zero blend-specific trials and no approval pathway.

klow · tier A

four-peptide clinic blend for skin, hair, collagen, and recovery. component logic first; blend evidence still missing.

tier rationale

a compounded blend of four peptides, each with its own mechanism: KPV (anti-inflammatory tripeptide from α-MSH) + GHK-Cu (collagen/skin) + BPC-157 (tissue/GI healing) + TB-500 (actin-binding, cell migration). the blend emerged from peptide clinic culture as an extension of the wolverine stack, adding cosmetic and anti-inflammatory components. A-tier because the mechanisms are genuinely complementary and the outcome pattern across compounding-pharmacy use is consistent. not S-tier because no controlled trial exists on the combination, and the component evidence is not uniformly S/A-tier.

at a glance

reptides grades the research record and cites the literature behind every call. research reference only; not medical advice.